Le Lézard
Classified in: Health
Subject: FVT

32 Rare Disease Charities Will Board the Historic LeRoy King Carousel at First-Ever RARE Carousel of Possible Dreams

ALISO VIEJO, Calif., Jan. 3, 2018 /PRNewswire-USNewswire/ -- Global Genes, a leading rare disease patient advocacy organization, and Festival of Children Foundation are proud to partner for the first-ever RARE Carousel of Possible Dreams on February 28, 2018 in San Francisco, at the Children's Creativity Museum. The inaugural event is a collaborative effort to support 32 rare disease charities 'dreams' by utilizing Festival of Children Foundation's well-known Carousel of Possible Dreams fundraiser on World Rare Disease Day.

Sandy Segerstrom Daniels takes a photo of actress and Global Genes ambassador, Madison McLaughlin, with Shira Strongin (rare disease patient advocate) at Festival of Children's Carousel of Possible Dreams at Disneyland in October 2016.

"We are so honored to partner with an exceptional organization that continuously gives back to children and families around the country," said Nicole Boice, CEO Global Genes. "This is an important time for the rare community. We know this partnership will allow rare charities and families the opportunity to learn how to increase awareness for their disease, while helping raise the much-needed funding for rare families."

The RARE Carousel of Possible Dreams will provide a unique fundraising opportunity for the 32 participating rare disease charities.  Rare Disease representatives will ride the celebrated LeRoy King Carousel over the course of the event to complete their individual pledge drives that will fund defined "dreams" or needs. The dreams range from funding scholarships and educational materials, to supporting family meet-ups, training tutors to work with rare disease children, emergency preparedness, and special customized wheel-chairs among many others.

"Working with Global Genes on this collaborative fundraiser is an incredible opportunity for Festival of Children Foundation," said Sandy Segerstrom Daniels, founder and executive director Festival of Children Foundation. "We are going to help realize dreams, change lives, bring hope to so many children and families in the Global Genes rare disease community." 

The inaugural RARE Carousel of Possible Dreams will take place on World Rare Disease Day, Wednesday, February 28 from 6 p.m. ? 8:30 p.m. at the Children's Creativity Museum. For more information, to register, or to join a team or donate, please visit festivalofchildren.org/SF18.

For a complete list of participating organizations visit: globalgenes.org/rarecarousel/.

About Global Genes
Global Genes is a leading global rare disease patient advocacy organization. The group's mission is to connect, empower and inspire the rare disease community. Recognized worldwide by the Blue Denim Genes Ribbontm, Global Genes unites experts, advocates and patients of all ages to stand together in hope for treatments and cures for the estimated 7,000 rare and genetic diseases that impact approximately 30 million Americans and over 350 million people worldwide.

About Festival of Children Foundation
Festival of Children Foundation is a 501 (c) (3) non-profit organization that serves to bring together and coordinate the efforts of charities, companies and individuals who actively work to improve the lives of children. Festival of Children Foundation gives a voice, guidance and support. 100% of the administrative costs are covered by designated funding, allowing donations to go further in direct support of programs and services that improve the lives of children. www.festivalofchildren.org

Global Genes logo

SOURCE Global Genes

These press releases may also interest you

20 mar 2018
WASHINGTON, Mar. 20, 2018 /PRNewswire-PRWeb/ -- Over the last several months, the Elizabeth Dole Foundation has been working across party lines in partnership with the leading veteran service organizations to expand the VA's Program of Comprehensive...

20 mar 2018
Centric Health Corporation ("Centric Health" or "the Company") , Canada's leading diversified healthcare services company, today reported its financial results for the fourth quarter ended December 31, 2017. Highlights for the Fourth Quarter of 2017...

20 mar 2018
BioPharmX Corporation , a specialty pharmaceutical company developing dermatology products, today announces that it has cancelled its presentation at Oppenheimer's 28th Annual Healthcare Conference in New York tomorrow, due to the winter storm...

20 mar 2018
WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it has selected 4,000 liter (L) Custom Single Run...

20 mar 2018
Proteostasis Therapeutics, Inc. , a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, announced...

20 mar 2018
Xencor, Inc. today announced the pricing of an underwritten public offering of 7,300,000 shares of its common stock at a price to the public of $31.00 per share. All of the shares are being sold by Xencor. The gross proceeds to Xencor from the...

News published on 3 january 2018 at 12:00 and distributed by: